...
首页> 外文期刊>Journal of inherited metabolic disease >Factor V Leiden mutation in Turkish patients with homozygous cystathionine beta-synthase deficiency.
【24h】

Factor V Leiden mutation in Turkish patients with homozygous cystathionine beta-synthase deficiency.

机译:纯合半胱氨酸胱氨酸β合酶缺乏症的土耳其患者中的V因子莱顿突变。

获取原文
获取原文并翻译 | 示例

摘要

Venous and arterial thromboembolism can occur in patients with homocystinuria. Resistance to activated protein C, which is caused by a single point mutation in the gene for factor V, renders an individual at risk for thrombosis. It has been suggested that coexistence of hereditary homocystinuria and factor V Leiden mutation might jointly play a role in the development of thrombosis. We analysed six patients with homocystinuria due to cystathionine beta-synthase deficiency for factor V Leiden and prothrombin G20210A mutations. Only one patient was found to have the factor V Leiden mutation in homozygous form and this patient had suffered from severe thrombosis. One patient was found to be heterozygous with no documented thrombosis. None of the patients had prothrombin G20210A mutation. We stress the necessity for screening for known thrombophilic risk factors in patients with cystathonine beta-synthase deficiency. The coexistence of the factor V Leiden mutation can cause severe thrombotic events in patients with homocystinuria.
机译:高半胱氨酸尿症患者可发生静脉和动脉血栓栓塞。由因子V基因的单点突变引起的对活化蛋白C的抗性使个体处于血栓形成的风险中。已经提出,遗传性高半胱氨酸尿症和因子V Leiden突变的共存可能在血栓形成的发展中共同起作用。我们分析了六名因胱硫醚β-合酶缺乏而导致的同型半胱氨酸尿症患者的V因子莱顿和凝血酶原G20210A突变。仅发现一名患者具有纯合子形式的V因子Leiden突变,并且该患者患有严重的血栓形成。发现一名患者为杂合子,无血栓形成。没有患者有凝血酶原G20210A突变。我们强调必须筛查胱胱氨酸β-合酶缺乏症患者的已知血栓形成危险因素。 V型莱顿突变的共存可导致高半胱氨酸尿症患者发生严重的血栓事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号